NCT02437656View on ClinicalTrials.gov

Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP).

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Rectal Cancer

Interventions

DRUG

Metformin

"J3 - J10 (7 days minimum) : 850 mg 2 times / day~J10 - 48h before surgery : 850 mg 3 times / day"

Trial Locations (11)

59000

Clinique du Bois - Centre Bourgogne, Lille

59020

Centre Oscar Lambret, Lille

59045

Centre Galilée - Hôpital Privé La Louvière, Lille

59240

Institut André Dutreix, Dunkirk

59300

Clinique des Dentellières, Valenciennes

59500

Centre Léonard de Vinci - SARL du pont Saint Vaast, Douai

59600

Centre Gray, Maubeuge

62000

Centre Marie Curie, Arras

62200

Centre Joliot-Curie, Saint-Martin-Boulogne

62300

Centre Hospitalier, Lens

62880

Centre Pierre Curie, Beuvry

All Listed Sponsors

lead

Centre Oscar Lambret

OTHER

NCT02437656 - Combination of Metformin to Neoadjuvant Radiochemotherapy in the Treatment of Locally Advanced Rectal Cancer (METCAP). | Biotech Hunter | Biotech Hunter